SCHEMBL2637204

SCHEMBL2637204

O=C(Nc1cccc(CO)c1)c1c(=O)[nH]n2c(=O)cc(-c3ccccc3)[nH]c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.43
ALOX12 P18054 1/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HDAC3 O15379 1/20 0.41
PTGER2 P43116 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
NHERF1 O14745 2/20 0.39
CNR2 P34972 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
PPARG P37231 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2637493 0.91 NHERF1 (0.46) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL2638043 0.88 MAPK10 (0.45) NPC1RAB9AMEN1KMT2AMAPK10
SCHEMBL2637592 0.86 MEN1 (0.45) NPC1RAB9AALDH1A1SMN1; SMN2MEN1
SCHEMBL2637207 0.82 CNR2 (0.45) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL2637918 0.81 KMT2A (0.41) NPC1RAB9AALDH1A1MAPK1SMN1; SMN2
SCHEMBL2637516 0.81 MEN1 (0.48) NPC1ALDH1A1MEN1KMT2AEGFR
SCHEMBL2637515 0.79 RAB9A (0.49) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL2637246 0.79 MAPK10 (0.41) RAB9AMAPTCNR2MEN1KMT2A
SCHEMBL2637180 0.79 CGAS (0.46) NPC1RAB9AALDH1A1MAPTMEN1
SCHEMBL2637520 0.78 DHODH (0.45) NPC1RAB9ANHERF1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2438070-A1 GLYCINE B ANTAGONISTS Merz Pharma GmbH & Co. KGaA (DE) 2012-04-11 EP disclosed
WO-2010139483-A1 GLYCINE B ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2010-12-09 WO disclosed